Registration Header

COVID-19 Briefing: The Second Wave

Start Date:10/8/2020

Start Time:11:30 AM EDT

Duration:60 minutes



If you're already registered for the COVID-19 Briefing: The Second Wave webcast, click below:



Armand Balboni

Dr. Balboni’s healthcare experience includes medical and drug development acumen in both civilian and military organizations. He is a founding partner and served as the senior advisor on scientific, regulatory, and medical affairs for the investment advisory firm Bloom Burton & Co., advising some of the most recent promising Canadian biotech companies. Dr. Balboni is also a Commissioned Officer in the U.S. Army with 17 years of military service including as the Deputy Director, Office of Regulated Activities (ORA),U.S. Army Medical Materiel Development Activity (USAMMDA). Dr. Balboni’s work in the ORA focused on regulatory filings (Emergency Use Authorizations, meetings, pre-sub filings etc.) for military-relevant medical products across all therapeutic areas. In addition, he completed a U.S. Department of Defense fellowship at the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) in the Division of Anti-infective Products, and in the Office of Counterterrorism and Emerging Threats (OCET). He also served as the Chief, Office of Research and Technology Application (ORTA), at the U.S. Army Research Institute of Infectious Disease (USAMRIID). Under his leadership, this office was responsible for the oversight of all strategic partnerships between USAMRIID and universities, U.S. and foreign government agencies, and biotechnology and pharmaceutical companies. Dr. Balboni has held various academic teaching positions including at Westfield State University, the University of Maryland University College, and the United States Military Academy at West Point. He completed his doctoral work in the MD/PhD program at the Icahn School of Medicine at Mount Sinai and his law degree (JD) at Brooklyn Law School.
First Name
Last Name
Email Address
©2019 West Corporation. All rights reserved.